Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
3
×
san francisco top stories
seattle blog main
3
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
celgene
clinical trials
drugs
fda
multiple myeloma
acc
acquisition
activist investor
aducanumab
age related macular degeneration
agios pharmaceuticals
alzheimer's failure
american college of cardiology
What
medical
3
×
week
3
×
adu
american
approved
ash
beats
bids
big
bio
biogen
biotechs
blood
chose
close
company
complicated
country
depression
device
diego
dire
disease
drug
firms
gathering
good
group
heart
help
hematology’s
ipo
ipos
largest
life
make
meeting
need
news
open
Language
Current search:
week
×
" seattle blog main "
×
medical
×
" san francisco blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way